Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease

Synapse

Volumn 63, Issue 7, 2009, Pages 541-548

  Muramatsu, Shin Ichi ^a   Okuno, Tsuyoshi ^b   Suzuki, Yutaka ^b   Nakayama, Takashi ^c   Kakiuchi, Takeharu ^d   Takino, Naomi ^a   Iida, Asako ^a   Ono, Fumiko ^e   Terao, Keiji ^e   Inoue, Nobuo ^f   Nakano, Imaharu ^a   Kondo, Yasushi ^b   Tsukada, Hideo ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d CENTRAL RESEARCH LABORATORY   (Japan)

^e NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^f TOKYO METROPOLITAN UNIVERSITY   (Japan)

Author keywords

ES cell; Monkey; MPTP; PET

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER C 11; CARBON 11; DOPAMINE; DOPAMINE TRANSPORTER; LEVODOPA BETA C 11; METHAMPHETAMINE; NEUROTOXIN; RACLOPRIDE C 11; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL THERAPY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MODEL; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; EMBRYONIC STEM CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MONKEY; MOUSE; NEURAL STEM CELL; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIMATE; PRIORITY JOURNAL; PUTAMEN; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CARBON RADIOISOTOPES; CELLS, CULTURED; COCAINE; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; EMBRYONIC STEM CELLS; LEVODOPA; MACACA FASCICULARIS; METHAMPHETAMINE; MOVEMENT DISORDERS; NEURONS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RACLOPRIDE; TYROSINE 3-MONOOXYGENASE;

EID: 67449083632     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20634     Document Type: Article

References (28)

1. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O. 2002. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99:2344-2349. (Pubitemid 34169063)
2. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569-2574.
3. Brooks DJ. 2004. Positron emission tomography imaging of transplant function. NeuroRx 1:482-491. (Pubitemid 46613780)
4. Chung S, Shin BS, Hwang M, Lardaro T, Kang UJ, Isacson O, Kim KS. 2006. Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells 24:1583-1593. (Pubitemid 44464676)
5. Hall VJ, Li JY, Brundin P. 2007. Restorative cell therapy for Parkinson's disease: A quest for the perfect cell. Semin Cell Dev Biol 18:859-869. (Pubitemid 350138454)
6. Huang SC, Barrio JR, Phelps ME. 1986. Neuroreceptor assay with positron emission tomography: Equilibrium versus dynamic approaches. J Cereb Blood Flow Metab 6:515-521. (Pubitemid 17198734)
7. Inoue N, Matsui H, Tsukui H, Hatanaka H. 1988. The appearance of a highly digitalis-sensitive isoform of Na+,K+-ATPase during maturation in vitro of primary cultured rat cerebral neurons. J Biochem (Tokyo) 104:349-354. (Pubitemid 18223282)
8. Isacson O, Bjorklund L, Pernaute RS. 2001. Parkinson's disease: Interpretations of transplantation study are erroneous. Nat Neurosci 4:553. (Pubitemid 32507363)
9. Jenner P. 2000. Factors influencing the onset and persistence of dyskinesia in MPTP-treated primates. Ann Neurol 47 (4 Suppl 1): S90-S99; discussion S99-S104. (Pubitemid 30192014)
10. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R. 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56. (Pubitemid 34742566)
11. Kish SJ, Shannak K, Hornykiewicz O. 1988. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318:876-880. (Pubitemid 18090271)
12. Li JY, Christophersen NS, Hall V, Soulet D, Brundin P. 2008. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 31:146-153.
13. Liu SV. 2008. iPS cells: A more critical review. Stem Cells Dev 17:391-397. (Pubitemid 351948206)
14. Mazloom M, Smith Y. 2006. Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. J Comp Neurol 495:453-469.
15. Nakayama T, Momoki-Soga T, Inoue N. 2003. Astrocyte-derived factors instruct differentiation of embryonic stem cells into neurons. Neurosci Res 46:241-249. (Pubitemid 36593287)
16. Nakayama T, Momoki-Soga T, Yamaguchi K, Inoue N. 2004. Efficient production of neural stem cells and neurons from embryonic stem cells. Neuroreport 15:487-491. (Pubitemid 38328146)
17. Newman MB, Bakay RA. 2008. Therapeutic potentials of human embryonic stem cells in Parkinson's disease. Neurotherapeutics 5:237-251.
18. Parent A, Hazrati LN. 1995. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20:91-127.
19. Piccini P, Lindvall O, Bjorklund A, Brundin P, Hagell P, Ceravolo R, Oertel W, Quinn N, Samuel M, Rehncrona S, Widner H, Brooks DJ. 2000. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 48:689-695. (Pubitemid 30823218)
20. Rodriguez-Gomez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD. 2007. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25:918-928.
21. Sanchez-Pernaute R, Studer L, Ferrari D, Perrier A, Lee H, Vinuela A, Isacson O. 2005. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells 23:914-922. (Pubitemid 41170947)
22. Suemori H, Tada T, Torii R, Hosoi Y, Kobayashi K, Imahie H, Kondo Y, Iritani A, Nakatsuji N. 2001. Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI. Dev Dyn 222:273-279. (Pubitemid 32937599)
23. Tabar V, Tomishima M, Panagiotakos G, Wakayama S, Menon J, Chan B, Mizutani E, Al-Shamy G, Ohta H, Wakayama T, Studer L. 2008. Therapeutic cloning in individual parkinsonian mice. Nat Med 14:379-381.
24. Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M, Hayashi H, Imazato T, Kawasaki H, Suemori H, Omachi S, Iida H, Itoh N, Nakatsuji N, Sasai Y, Hashimoto N. 2005. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115:102-109.
25. Tsukada H, Harada N, Nishiyama S, Ohba H, Kakiuchi T. 2000a. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: Positron emission tomography studies with microdialysis in the conscious monkey brain. J Neurosci 20:7067-7073. (Pubitemid 30708035)
26. Tsukada H, Harada N, Nishiyama S, Ohba H, Sato K, Fukumoto D, Kakiuchi T. 2000b. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis. Synapse 37:95-103.
27. Watanabe M, Okada H, Shimizu K, Omura T, Yoshikawa E, Kosugi T, Mori S, Yamashita T. 1997. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans Nucl Sci 44:1277-1282. (Pubitemid 127827087)
28. Wichmann T, DeLong MR. 2003. Pathophysiology of Parkinson's disease: The MPTP primate model of the human disorder. Ann N Y Acad Sci 991:199-213. (Pubitemid 36793815)